These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 19261924)

  • 1. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
    Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
    Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
    Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
    AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraaxial brain masses: MR imaging-based diagnostic strategy--initial experience.
    Al-Okaili RN; Krejza J; Woo JH; Wolf RL; O'Rourke DM; Judy KD; Poptani H; Melhem ER
    Radiology; 2007 May; 243(2):539-50. PubMed ID: 17456876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
    Park BK; Kim CK; Kim B; Lee JH
    Radiology; 2007 Jun; 243(3):760-5. PubMed ID: 17517932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.
    Cha S; Pierce S; Knopp EA; Johnson G; Yang C; Ton A; Litt AW; Zagzag D
    AJNR Am J Neuroradiol; 2001; 22(6):1109-16. PubMed ID: 11415906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.
    Marin D; Di Martino M; Guerrisi A; De Filippis G; Rossi M; Ginanni Corradini S; Masciangelo R; Catalano C; Passariello R
    Radiology; 2009 Apr; 251(1):85-95. PubMed ID: 19332848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic tibiofibular syndesmosis injury of ankle: evaluation with contrast-enhanced fat-suppressed 3D fast spoiled gradient-recalled acquisition in the steady state MR imaging.
    Kim S; Huh YM; Song HT; Lee SA; Lee JW; Lee JE; Chung IH; Suh JS
    Radiology; 2007 Jan; 242(1):225-35. PubMed ID: 17185669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Central nervous system involvement of leukemia and systemic lymphoma in children: CT and MR findings].
    Tomura N; Hirano H; Kato K; Sashi R; Hashimoto M; Watarai J; Watanabe A
    No To Shinkei; 1997 Nov; 49(11):993-1000. PubMed ID: 9396030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions.
    Lu SS; Kim SJ; Kim N; Kim HS; Choi CG; Lim YM
    AJR Am J Roentgenol; 2015 Apr; 204(4):827-34. PubMed ID: 25794073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
    Low RN; Barone RM; Lacey C; Sigeti JS; Alzate GD; Sebrechts CP
    Radiology; 1997 Aug; 204(2):513-20. PubMed ID: 9240546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR imaging, CT, and cholangiography.
    Low RN; Sigeti JS; Francis IR; Weinman D; Bower B; Shimakawa A; Foo TK
    AJR Am J Roentgenol; 1994 Feb; 162(2):315-23. PubMed ID: 8310918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
    Yasumoto M; Shibuya H; Takeda M; Korenaga T
    AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images.
    Burns PN; Wilson SR
    Radiology; 2007 Jan; 242(1):162-74. PubMed ID: 17090710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful?
    Vliegen RF; Beets GL; von Meyenfeldt MF; Kessels AG; Lemaire EE; van Engelshoven JM; Beets-Tan RG
    Radiology; 2005 Jan; 234(1):179-88. PubMed ID: 15550372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
    Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
    Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.
    Lin G; Ng KK; Chang CJ; Wang JJ; Ho KC; Yen TC; Wu TI; Wang CC; Chen YR; Huang YT; Ng SH; Jung SM; Chang TC; Lai CH
    Radiology; 2009 Mar; 250(3):784-92. PubMed ID: 19244045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging of pelvic masses in women: contrast-enhanced vs unenhanced images.
    Thurnher SA
    AJR Am J Roentgenol; 1992 Dec; 159(6):1243-50. PubMed ID: 1442393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
    Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging.
    Fretz CJ; Stark DD; Metz CE; Elizondo G; Weissleder R; Shen JH; Wittenberg J; Simeone J; Ferrucci JT
    AJR Am J Roentgenol; 1990 Oct; 155(4):763-70. PubMed ID: 2119106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.